Comparison of aspirin and rivaroxaban for the prevention of pulmonary embolism and deep vein thrombosis in high thrombotic risk patients with systemic lupus erythematosus: study protocol for a multicentre, prospective, randomised controlled trial.
Thromboembolic events are an important cause of morbidity and mortality in systemic lupus erythematosus (SLE). Current thromboprophylaxis recommendations mainly focus on patients with antiphospholipid syndrome or persistent antiphospholipid antibody (aPL) positivity, whereas pre…